Search your stocks

Share

Profile

BIOCONBiocon Ltd.

368.8(+0.11%)

1W: +1.07%

1M: -1.06%

1Y: +36.60%

Financials

Charts

YoY Net Sales

Operating Margin

EPS Growth

Pros & Cons

POSITIVES

Recent quarter shows strong revenue growth of 10.5% YoY, indicating robust market demand.
Operating profit margin surged to 9.72% in Q2 2024, reflecting improved cost management.
Net profit rebounded to ₹81.10 Crore in Q4 2024 from ₹27.10 Crore in Q3, signaling recovery.

NEGATIVES

Net profit dropped significantly from ₹861.80 Crore in Q2 2024 to ₹27.10 Crore in Q3, raising concerns.
Expenses increased due to higher material costs, impacting profitability.
Quarterly revenue decline in Q2 2024 suggests potential seasonal volatility in demand.

Quarterly Results Data

Field	Trend	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue		3,462.30	3,953.70	3,917.10	3,432.90	3,590.40	3,821.40	4,417	3,941.90
Expenses		3,357.70	3,708.10	3,635.20	3,453.90	3,550.50	3,718.40	3,987.50	3,924.70
Operating Profit		104.60	245.60	281.90	-21	39.90	103	429.50	17.20
Other Income		157.90	565.50	48.60	1,134.50	32.50	34.80	36.90	79.70
Interest		247.70	266.70	227	236	225.60	223.40	212.40	276.70
Depreciation		389.30	414.50	407	405.40	419.90	425.40	436.30	455
Profit Before Tax		214.30	808.20	319	1,145.50	98.40	155.90	486.80	96.90
Tax		41.60	54.90	96.10	283.70	71.30	74.80	27.40	7.70
Net Profit		172.70	753.30	222.90	861.80	27.10	81.10	459.40	89.20
Eps in Rs		1.05	5.52	1.13	5.51	-0.13	0.21	2.88	0.26